IRCT20090117001556N104招募中3 期
Resveratrol add on therapy to risperidone in irritibility of children with autism: a randomized double-blind placebo-controlled clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 years 至 12 years（—）
- 性别
- All
入选标准
- •DSM-5 clinical diagnosis of autistic disorder
- •children between the ages of 3 and 12 years
- •presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone)
排除标准
- •Presence of any active medical problem
- •other psychiatric diagnosis except for mild to moderate Intellectual disability
- •receiving any antipsychotic medications during past monthprior to the trial
- •severe hepatic disease
- •history of allergy to risperidone and intolerance of it
- •History of seizure requiring change of antiepileptic dose during the last month
- •seizure during the last 6 months
研究者
相似试验
招募中
3 期
Resveratrol in the treatment of chronic schizophreniaschizophrenia.SchizophreniaIRCT20090117001556N103Tehran University of Medical Sciences60
已完成
不适用
Simvastatin in the treatment of AutismAutistic Disorder.Childhood autismIRCT201602041556N86Tehran University of Medical Sciences40
招募中
3 期
Folinic acid in the treatment of autism spectrum disorderAutistic disorder.Autistic disorderF84.0IRCT20090117001556N114Tehran University of Medical Sciences50
已完成
2 期
Riluzole in the treatment of autismChildhood autism.Childhood autismIRCT201107281556N27Tehran University of Medical Sciences40
已完成
2 期
Sildenafil the treatment of the negative symptoms of schizophreniaSchizophrenia.SchizophreniaIRCT1138901151556N11Tehran University of Medical Sciences40